MeSH tree: D12.776.780
Researchers have uncovered a biological mechanism that helps explain why hepatitis E virus infections can be especially severe—and often fatal—during pregnancy, finding that normal pregnancy-related hormonal changes inadvertently ...
Aug 26, 2026
0
7
A new model developed by researchers at Kumamoto University and collaborators from Tohoku University and Kyushu University could advance research into preeclampsia and other pregnancy complications. The team has developed ...
Aug 25, 2026
0
5
Most women experience some nausea and vomiting in early pregnancy.
Jan 13, 2026
0
12
Per- and polyfluoroalkyl substances (PFAS) are a group of nearly 10,000 long-lasting chemical compounds that stay in the environment and have been linked to adverse health effects on humans, including pregnant women and their ...
Dec 4, 2025
0
15
In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring levels of a protein associated with placental function and development.
Oct 21, 2025
0
6
Two simple blood tests could help to predict which pregnant women with high blood pressure are at risk of serious complications, including seizures, stillbirth and newborn death, a new study conducted in Sierra Leone has ...
Sep 19, 2025
0
21
A simple fitness tracker might hold the key to revolutionizing maternal health care. Scientists at Scripps Research have found preliminary evidence suggesting that common wearable devices such as the Apple Watch, Garmin and ...
Sep 12, 2025
0
42
A research team from Sinai Health and the University of Toronto has identified a way to determine which mothers are more likely to deliver a baby preterm, raising the possibility of developing a universal screening strategy.
Feb 19, 2025
0
21
To identify and follow blood vessel-related changes in the brain that contribute to cognitive impairment and dementia, researchers and clinicians typically rely on MRI to evaluate "downstream" biological markers—those at ...
Dec 18, 2024
0
20
PARP inhibitors have improved survival of breast cancer patients with BRCA1/2 mutations, but the drugs eventually stop working and the cancer returns.
Aug 15, 2024
0
45
